428 related articles for article (PubMed ID: 19636100)
21. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
Derakhshandeh K; Erfan M; Dadashzadeh S
Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
[TBL] [Abstract][Full Text] [Related]
22. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
Chung TW; Wang SS; Tsai WJ
Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984
[TBL] [Abstract][Full Text] [Related]
23. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells.
Tahara K; Kato Y; Yamamoto H; Kreuter J; Kawashima Y
J Microencapsul; 2011; 28(1):29-36. PubMed ID: 21171814
[TBL] [Abstract][Full Text] [Related]
24. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers.
Beletsi A; Panagi Z; Avgoustakis K
Int J Pharm; 2005 Jul; 298(1):233-41. PubMed ID: 15936907
[TBL] [Abstract][Full Text] [Related]
25. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system.
Tahara K; Furukawa S; Yamamoto H; Kawashima Y
Int J Pharm; 2010 Jun; 392(1-2):311-3. PubMed ID: 20347023
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of highly-magnetic biodegradable poly(d,l-lactide-co-glycolide) nanospheres.
Liu X; Kaminski MD; Chen H; Torno M; Taylor L; Rosengart AJ
J Control Release; 2007 May; 119(1):52-8. PubMed ID: 17350131
[TBL] [Abstract][Full Text] [Related]
27. Prolonged analgesic effect of PLGA-encapsulated bee venom on formalin-induced pain in rats.
Jeong I; Kim BS; Lee H; Lee KM; Shim I; Kang SK; Yin CS; Hahm DH
Int J Pharm; 2009 Oct; 380(1-2):62-6. PubMed ID: 19577620
[TBL] [Abstract][Full Text] [Related]
28. PLGA micro/nanosphere synthesis by droplet microfluidic solvent evaporation and extraction approaches.
Hung LH; Teh SY; Jester J; Lee AP
Lab Chip; 2010 Jul; 10(14):1820-5. PubMed ID: 20467687
[TBL] [Abstract][Full Text] [Related]
29. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
Yin J; Noda Y; Yotsuyanagi T
Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494
[TBL] [Abstract][Full Text] [Related]
30. Composites of poly(lactide-co-glycolide) and the surface modified carbonated hydroxyapatite nanoparticles.
Hong Z; Zhang P; Liu A; Chen L; Chen X; Jing X
J Biomed Mater Res A; 2007 Jun; 81(3):515-22. PubMed ID: 17133447
[TBL] [Abstract][Full Text] [Related]
31. In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold.
Zhu XH; Wang CH; Tong YW
J Biomed Mater Res A; 2009 May; 89(2):411-23. PubMed ID: 18431776
[TBL] [Abstract][Full Text] [Related]
32. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro.
Jin C; Bai L; Wu H; Tian F; Guo G
Biomaterials; 2007 Sep; 28(25):3724-30. PubMed ID: 17509678
[TBL] [Abstract][Full Text] [Related]
33. Fabrication and characterization of permeable degradable poly(DL-lactide-co-glycolide) (PLGA) hollow fiber phase inversion membranes for use as nerve tract guidance channels.
Wen X; Tresco PA
Biomaterials; 2006 Jul; 27(20):3800-9. PubMed ID: 16564567
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis.
Kumar G; Sharma S; Shafiq N; Pandhi P; Khuller GK; Malhotra S
Drug Deliv; 2011 Jan; 18(1):65-73. PubMed ID: 20735202
[TBL] [Abstract][Full Text] [Related]
35. Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel.
Jackson JK; Smith J; Letchford K; Babiuk KA; Machan L; Signore P; Hunter WL; Wang K; Burt HM
Int J Pharm; 2004 Sep; 283(1-2):97-109. PubMed ID: 15363506
[TBL] [Abstract][Full Text] [Related]
36. Adriamycin release from self-assembling nanospheres of poly(DL-lactide-co-glycolide)-grafted pullulan.
Jeong YI; Na HS; Oh JS; Choi KC; Song CE; Lee HC
Int J Pharm; 2006 Sep; 322(1-2):154-60. PubMed ID: 16891068
[TBL] [Abstract][Full Text] [Related]
37. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone.
Teixeira M; Alonso MJ; Pinto MM; Barbosa CM
Eur J Pharm Biopharm; 2005 Apr; 59(3):491-500. PubMed ID: 15760730
[TBL] [Abstract][Full Text] [Related]
38. Interaction of PLGA nanoparticles with human blood constituents.
Kim D; El-Shall H; Dennis D; Morey T
Colloids Surf B Biointerfaces; 2005 Feb; 40(2):83-91. PubMed ID: 15642458
[TBL] [Abstract][Full Text] [Related]
39. A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres.
Li H; Tran VV; Hu Y; Mark Saltzman W; Barnstable CJ; Tombran-Tink J
Exp Eye Res; 2006 Oct; 83(4):824-33. PubMed ID: 16822505
[TBL] [Abstract][Full Text] [Related]
40. Controlled assembly of poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres under ultrasonic irradiation.
Jevtić M; Radulović A; Ignjatović N; Mitrić M; Uskoković D
Acta Biomater; 2009 Jan; 5(1):208-18. PubMed ID: 18753023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
